India's lack of patent protection has been of concern to many foreign pharma companies. This is Ajay Piramal's humanitarian perspective on the pricing of drugs.

Ajay Gopikisan Piramal is Chairman of the Piramal Group, a conglomerate with interests in pharmaceutical, financial services, real estate, healthcare analytics and glass packaging. In 1977, at age 22, Piramal started out in his family's textile business, founded in 1934 by his grandfather Piramal Chatrabhuj. His father, Gopikisan Piramal, died in 1979, and after five years he lost an older brother to cancer, prompting him to take over the business. Piramal holds a bachelor's degree in Science from the Jai Hind College and Basantsingh Institute of Science, University of Mumbai (then Bombay), a master's degree in management studies from Jamnalal Bajaj Institute of Management Studies, University of Mumbai, and in 1992 attended the six-week Advanced Management Programme at Harvard Business School.[5] Piramal has received an honorary doctorate by Amity University, India[7] and Honorary Doctor of Science from IIT Indore.

Insights

Pharma: Profit vs Human Life